Through additional experiments we excluded B-RAF and confirmed that c-MYC positively modulates NRF2 through binding to the NRF2 promoter region in HNSCC cells (Figure 2G-2J). The gene discussed is MYC; the disease is head and neck squamous cell carcinoma.